Harrow Announces Second-Quarter 2025 Financial Results

Go back to Harrow Announces Second-Quarter 2025 Financial Results

Harrow Health (HROW) Tops Q2 EPS by 23c, Misses on Revenue

August 11, 2025 4:02 PM EDT

Harrow Health (NASDAQ: HROW) reported Q2 EPS of $0.24, $0.23 better than the analyst estimate of $0.01. Revenue for the quarter came in at $63.7 million versus the consensus estimate of $66 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

... More